16 episodes

Welcome to The SynBioBeta Podcast: Conversations with synthetic biology’s leading thinkers on building a better world with biology. Hosted by John Cumbers, founder and CEO of SynBioBeta, where tech meets bio and bio meets tech.


Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


Twitter | LinkedIn | Facebook

The SynBioBeta Podcast John Cumbers

    • Science
    • 5.0 • 10 Ratings

Welcome to The SynBioBeta Podcast: Conversations with synthetic biology’s leading thinkers on building a better world with biology. Hosted by John Cumbers, founder and CEO of SynBioBeta, where tech meets bio and bio meets tech.


Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


Twitter | LinkedIn | Facebook

    How nature co-design is changing the narrative - with Massimo Portincaso

    How nature co-design is changing the narrative - with Massimo Portincaso

    Today John Cumbers talks with Massimo Portincaso, managing director and partner at BCG. John will be talking to Massimo about what nature co-design, how we're shifting from global supply chains to global value chains, what distributed biological manufacturing is, and more..


    Massimo Portincaso co-leads the Deep Tech Mission, BCG’s unit focused on the deep tech approach to innovation, emerging technologies, and the new rules of engagement for all actors in the innovation space. He is also the Chairman of Hello Tomorrow, an organization dedicated to unlocking the power of deep tech to solve the toughest global challenges.


    You can keep up with Massimo through his newsletter, The Antidisciplinarian, which covers happenings at the intersection of matter, computation, sensing, creativity, and ethics.


    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to our SynBioBeta events! Click here for more information.

    • 39 min
    Where brands and biology meet - with Karl Schmieder

    Where brands and biology meet - with Karl Schmieder

    Today John Cumbers talks with Karl Schmieder the founder of messagingLAB, a strategy and consulting firm that helps biotechnology and synthetic biology companies create and execute strategies to drive the industry forward.


    Connect with Karl: @karlschmieder


    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to SynBioBeta Brand and Biology event December 2nd & 3rd! Click here for more information.

    • 30 min
    Does eating animals cause pandemics? - with Ryan Bethencourt of Wild Earth

    Does eating animals cause pandemics? - with Ryan Bethencourt of Wild Earth

    Today John Cumbers talks with Ryan Bethencourt, founder and CEO of Wild Earth. John will be talking to Ryan about the state of COVID and questions like "Does eating animals cause pandemics?"


    Recorded live on: March 15th, 2020


    To watch the video component: https://www.facebook.com/SynBioBeta/videos/199598178035525/


    Connect with Ryan: @RyanBethencourt


    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to SynBioBeta 2020 this September 29 - October 1! Click here for more information.

    • 1 hr 20 min
    How DNA synthesis is powering the fourth manufacturing revolution - with Emily Leproust

    How DNA synthesis is powering the fourth manufacturing revolution - with Emily Leproust

    Today John Cumbers talks with Emily Leproust, Entrepreneur and CEO of Twist Bioscience. John will be talking to Emily about why she founded Twist, the many industries that will be disrupted by DNA technology, and how Twist is building a company culture for growth diversity and excellence.


    Emily is the co founder and the CEO of Twist Bioscience, an early pioneer in high throughput synthesis and sequencing of DNA. Emily is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in many fields, including medicine, DNA, data storage, agriculture biology, and industrial chemicals.


     


    Connect with Emily.: @EmilyLeproust


    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to SynBioBeta 2020 this September 29 - October 1! Click here for more information.

    • 58 min
    How protein engineering is the killer app for biology - with John Nichols

    How protein engineering is the killer app for biology - with John Nichols

    Today John Cumbers talks with John Nicols, President and CEO of Codexis, a leading protein engineering company here in Silicon Valley. I’ll be talking with John about “How protein engineering is the killer app for biology.” Specifically, I’ll talk with John about the amazing pedigree and origins of Codexis, how companies like Codexis are changing the way the biopharma industry does business, and John’s vision for how protein engineering is going to impact our daily lives.






    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to SynBioBeta 2020 this September 29 - October 1! Click here for more information.

    • 1 hr 14 min
    How an artist becomes an investor and advisor to the world’s greatest technology companies - with D.A. Wallach

    How an artist becomes an investor and advisor to the world’s greatest technology companies - with D.A. Wallach

    Today John Cumbers talks with D.A. Wallach, recording artist and emerging tech investor. John will be talking to D.A. about his journey from performing artist to investor in emerging tech, how his unique background informs his investment thesis, and what opportunities he’s most excited about in synthetic biology these days.


     


    D.A. Wallach is a recording artist, songwriter, and investor. While an undergraduate at Harvard, he was discovered by Kanye West and Pharrell Williams. As a solo artist, D.A. is signed by Harvest Records, a subsidiary of Capitol Records, and he is the former artist-in-residence at Spotify, a company where he was an early investor. Beyond music, D.A. invests in and advises several start-up technology companies, including Synthego, Glypse Bio, Beam Therapeutics, SpaceX, Ripple. Forbes selected D.A. as one of its 30 Under 30, and Fast Company named him one of the 100 Most Creative People in Business. In 2015, he launched Inevitable Ventures, an investment partnership with multibillionaire Ron Burkle that supports radical entrepreneurs in areas including health care, life sciences, and financial technologies. He is also an advisor to The Dreamers Fund, a partnership with actor Will Smith.


     


    Connect with D.A.: @dawallach


    Connect with John: @johncumbers


    Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:


    Twitter | LinkedIn | Facebook


    Be sure you make it to SynBioBeta 2019 this October 1-3! Click here for more information.

    • 52 min

Customer Reviews

5.0 out of 5
10 Ratings

10 Ratings

KingPanda000 ,

Worth It

John is a fascinating guy with a talent for evoking fascinating things out of his guests. I never quite realized how big a deal synthetic biology is. Podcast is still new but the first three episodes are great. looking forward to more.

Top Podcasts In Science

Listeners Also Subscribed To